IgA肾病中miR-150-5p的差异表达:疾病进展的潜在介导因子与标志物
该研究通过对肾活检组织进行下一代测序的miRNome分析,识别与IgA肾病进展风险相关的microRNA。在独立队列验证后,发现四个microRNA在进展者与非进展者间差异表达,并与eGFR、蛋白尿及Oxford MEST-C评分相关。miR-150-5p在队列间表达振幅最大,ROC分析区分进展者与非进展者的AUC为0.8,但其在已建立纤维化和低eGFR的肾脏中同样上调,提示其可能为肾脏纤维化的通用功能介导因子。
要点
- 四个microRNA在IgA肾病进展者中差异表达,并与eGFR、蛋白尿及MEST-C评分相关。
- miR-150-5p区分进展者与非进展者的AUC为0.8,但样本量小未达统计学显著性。
- miR-150-5p在已建立纤维化和低eGFR的肾脏中同样上调,提示通用纤维化角色。
核心结论
- miR-150-5p可能是肾脏纤维化的潜在功能介导因子,可能为预测IgA肾病及其他肾脏疾病进展风险提供价值。
研究设计与样本
- 对肾活检组织进行下一代测序的miRNome分析,并在独立队列中验证。
主要发现
- 四个microRNA(-150-5p、-155-5p、-146b-5p、-135a-5p)在IgA肾病进展者与非进展者间差异表达,并与eGFR、蛋白尿及Oxford MEST-C评分相关。
- 每个microRNA均提高国际IgA肾病预测工具的区分评分,但因样本量小未达统计学显著性。
- miR-150-5p在队列间表达振幅最大,ROC分析区分进展者与非进展者的AUC为0.8。
- miR-150-5p在已建立纤维化和活检时低eGFR的肾脏中同样上调。
- 原位杂交显示miR-150-5p存在于淋巴浸润、增殖和纤维化区域。
临床怎么用
- miR-150-5p可能作为预测IgA肾病进展风险的候选标志物,但需更大样本验证。
局限性
- 样本量小,microRNA提高预测工具区分评分的结果未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Understanding why certain patients with IgA nephropathy progress to kidney failure while others maintain normal kidney function remains a major unanswered question. To help answer this, we performed miRNome profiling by next generation sequencing of kidney biopsies in order to identify microRNAs specifically associated with the risk of IgA nephropathy progression. Following sequencing and validation in independent cohorts, four microRNAs (-150-5p, -155-5p, -146b-5p, -135a-5p) were found to be differentially expressed in IgA nephropathy progressors compared to non-progressors, and patients with thin membrane nephropathy, lupus nephritis and membranous nephropathy, and correlated with estimated glomerular filtration rate, proteinuria, and the Oxford MEST-C scores (five histological features that are independent predictors of clinical outcome). Each individual microRNA increased the discrimination score of the International IgAN Prediction Tool, although due to the small number of samples the results did not reach statistical significance. miR-150-5p exhibited the largest amplitude of expression between cohorts and displayed the best discrimination between IgA nephropathy progressors and non-progressors by receiver operating curve analysis (AUC: 0.8). However, expression was similarly upregulated in kidneys with established fibrosis and low estimated glomerular filtration rates at the time of biopsy. Consistent with a more generic role in kidney fibrosis, in situ hybridization revealed that miR-150-5p was found in lymphoid infiltrates, and areas of proliferation and fibrosis consistent with the known drivers of progression. Thus, miR-150-5p may be a potential functional mediator of kidney fibrosis that may add value in predicting risk of progression in IgA nephropathy and other kidney diseases.
引用
- Pawluczyk IZA, Didangelos A, Barbour SJ, et al. Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression. Kidney Int. 2021. PMID: 33417998. doi:10.1016/j.kint.2020.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。